Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç
Measurement using Korean Adult Attention-deficit hyperactivity disorder Self Report Scale (K-ASRS)
½Åä¹Î, ÀÌ´Ù¼Ø, ÃÖ¿øÁ¤, ÀÌ¿ù¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
½Åä¹Î ( Shin Chae-Min ) - National Evidence-based Healthcare Collaborating Agency
ÀÌ´Ù¼Ø ( ) - National Evidence-based Healthcare Collaborating Agency
ÃÖ¿øÁ¤ ( Choi Won-Jung ) - National Evidence-based Healthcare Collaborating Agency
ÀÌ¿ù¼÷ ( Lee Worl-Sook ) - National Evidence-based Healthcare Collaborating Agency
KMID : 9000120210010280001
Abstract
½Åû±â¼ú : Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç
Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç(Measurement using Korean Adult ADHD Self Report Scale, K-ASRS)´Â ¼ºÀÎ ADHD ÀÇ½É È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÀÚ°¡º¸°íôµµ¸¦ ÀÌ¿ëÇÏ¿© ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶Çϱâ À§ÇÑ ±â¼úÀÌ´Ù. µ¿ ±â¼úÀº ÀÇ·á¹ý Á¦53Á¶ ¹× ½ÅÀÇ·á±â¼úÆò°¡¿¡ °üÇÑ ±ÔÄ¢ Á¦3Á¶ÀÇ ±ÔÁ¤¿¡ µû¶ó "¼ºÀοë ADHD Áõ»ó ôµµ(ADHD Self Report Scale)" ¶ó´Â ¸íĪÀ¸·Î 2020³â 9¿ù 10ÀÏ¿¡ ½ÅûµÇ¾ú´Ù. ¼ÒÀ§¿øÈ¸¿¡¼´Â ¾È°Ç¿¡ ´ëÇÑ ¸íÈ®ÇÑ ÀÌÇØ¸¦ À§ÇØ ¡°Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç¡±·Î ÀÇ·á±â¼ú¸íÀ» º¯°æÇÏ¿´´Ù.
½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸ ¹× ¼ÒÀ§¿øÈ¸ ¿î¿µ
2020³â Á¦10Â÷ ½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸(2020.10.23.)¿¡¼´Â ¾ÈÀü¼º ¹× À¯È¿¼º¿¡ ´ëÇÑ Æò°¡°¡ ÇÊ¿äÇÑ ½ÅÀÇ·á±â¼ú Æò°¡´ë»óÀ¸·Î ÆÇ´ÜÇϰí, ü°èÀû ¹®Çå°íÂû ¹æ¹ý µîÀ¸·Î ÃÑ 7ÀÎ(Á¤½Å°Ç°ÀÇÇаú 4ÀÎ, ¼Ò¾ÆÃ»¼Ò³â°ú 2ÀÎ, ±Ù°Å±â¹ÝÀÇÇÐ 1ÀÎ)À¸·Î ±¸¼ºµÈ ¼ÒÀ§¿øÈ¸¿¡¼ Æò°¡Çϵµ·Ï ½ÉÀÇÇÏ¿´´Ù.
¼ÒÀ§¿øÈ¸¿¡¼´Â 2021³â 1¿ù 13ÀϺÎÅÍ 2021³â 2¿ù 23ÀϱîÁö ÃÑ 2ȸÀÇ È¸ÀǸ¦ ÅëÇØ ¼±ÅÃµÈ ¿¬±¸ÀÇ °á°ú¿¡ µû¶ó µ¿ ±â¼úÀ» Æò°¡ÇÏ°í °ËÅä°á°ú¸¦ Á¦ÃâÇÏ¿´À¸¸ç, 2021³â Á¦3Â÷ ½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸(2021.3.26.)¿¡¼ ÇØ´ç ³»¿ëÀ» Åä´ë·Î µ¿ ±â¼úÀ» ÃÖÁ¾ ½ÉÀÇÇÏ¿´´Ù.
Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç Æò°¡
Æò°¡¸ñÀû
Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç´Â ¼ºÀÎ ADHD ÀÇ½É È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÀÚ°¡º¸°íôµµ¸¦ ÀÌ¿ëÇÏ¿© ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶Çϱâ À§ÇÑ ±â¼ú·Î, º» Æò°¡ÀÇ ¸ñÀûÀº µ¿ ±â¼úÀÇ ¾ÈÀü¼º ¹× À¯È¿¼ºÀ» È®ÀÎÇϴµ¥ ÀÖ´Ù.
Æò°¡¹æ¹ý
µ¿ ±â¼úÀÇ Æò°¡´Â ü°èÀû ¹®Çå°íÂûÀ» ÅëÇØ ÁøÇàÇÏ¿´´Ù. ¾ÈÀü¼ºÀº µ¿ ±â¼úÀÌ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶ÇÏ´Â ±â¼ú·Î ȯÀÚ¿¡°Ô Á÷Á¢ÀûÀÎ À§Çظ¦ °¡ÇÏÁö ¾Ê¾Æ ÁßÀç¹ý ¼öÇà¿¡ µû¸¥ ¾ÈÀü¼º¿¡´Â ¹®Á¦°¡ ¾ø´Â °ÍÀ¸·Î Æò°¡ÇÏ¿´À¸¸ç, À¯È¿¼ºÀº ½Å·Úµµ(³»Àû ÀÏÄ¡µµ, °Ë»ç-Àç°Ë»ç ½Å·Úµµ)¹× Ÿ´çµµ(Âü°íÇ¥ÁØ/ºñ±³°Ë»ç¿ÍÀÇ »ó°ü¼º ¹× ÀÏÄ¡µµ, Áø´ÜÁ¤È®¼º)·Î Æò°¡ÇÏ¿´´Ù. ¹®Çå°Ë»öÀº KoreaMed¸¦ Æ÷ÇÔÇÑ 5°³ ±¹³» µ¥ÀÌÅͺ£À̽º¿Í Ovid-MEDLINE, Ovid-EMBASE, Cochrane Library ¹× PsycinfoÀÇ ±¹¿Ü µ¥ÀÌÅͺ£À̽º¸¦ ÀÌ¿ëÇÏ¿´´Ù. ¹®Çå¼±ÅÃÀº ¹®Çå°Ë»öÀ» ÅëÇØ 982ÆíÀÇ ¹®ÇåÀ» È®ÀÎÇÏ¿´À¸¸ç, Áߺ¹ °Ë»öµÈ ¹®ÇåÀ» Á¦¿ÜÇÑ ¹®ÇåÀ» Åä´ë·Î ¼±Åà ¹× ¹èÁ¦±âÁØÀ» Àû¿ëÇÏ¿© ÃÑ 2ÆíÀÇ ¹®ÇåÀÌ ÃÖÁ¾ Æò°¡¿¡ Æ÷ÇԵǾú´Ù.
¹®Çå°Ë»öºÎÅÍ ¼±ÅñâÁØ Àû¿ë ¹× ÀÚ·áÃßÃâ±îÁö °¢ ´Ü°è´Â ¸ðµÎ ¼ÒÀ§¿øÈ¸¿Í ¾Æ¿ï·¯ 2¸íÀÇ Æò°¡ÀÚ°¡ µ¶¸³ÀûÀ¸·Î ¼öÇàÇÏ¿´´Ù. ¹®ÇåÀÇ Áú Æò°¡´Â Scottish Intercollegiate Guidelines NetworkÀÇ µµ±¸¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç, ÀÌ¿¡ µû¶ó Áú Æò°¡ °á°ú¿Í ±Ù°ÅÀÇ ¼öÁØÀ» ¼±Á¤ÇÏ¿© Æò°¡°á°ú¸¦ ±â¼úÇÏ¿´´Ù.
Æò°¡°á°ú
µ¿ ±â¼úÀÇ ¾ÈÀü¼º ¹× À¯È¿¼ºÀº 2Æí(Áø´Ü¹ý Æò°¡¿¬±¸)ÀÇ ¹®Çå¿¡ ±Ù°ÅÇÏ¿© Æò°¡ÇÏ¿´À¸¸ç Áú Æò°¡ °á°ú´Â ¡®2+¡¯¿´´Ù.
¾ÈÀü¼º
µ¿ ±â¼úÀº ¼ºÀÎ ADHD ÀÇ½É È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÀÚ°¡º¸°íôµµ¸¦ ÀÌ¿ëÇÏ¿© ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶ÇÏ´Â ±â¼ú·Î ȯÀÚ¿¡°Ô Á÷Á¢ÀûÀÎ À§Çظ¦ °¡ÇÏÁö ¾Ê¾Æ ÁßÀç¹ý ¼öÇà¿¡ µû¸¥ ¾ÈÀü¼º¿¡´Â ¹®Á¦°¡ ¾ø´Â °ÍÀ¸·Î Æò°¡ÇÏ¿´´Ù.
À¯È¿¼º
µ¿ ±â¼úÀÇ À¯È¿¼ºÀº ÃÑ 2Æí(Áø´Ü¹ý Æò°¡¿¬±¸)ÀÇ ¹®Çå¿¡ ±Ù°ÅÇÏ¿© ½Å·Úµµ(³»Àû ÀÏÄ¡µµ, °Ë»ç-Àç°Ë»ç ½Å·Úµµ)¹× Ÿ´çµµ(Âü°íÇ¥ÁØ/ºñ±³°Ë»ç¿ÍÀÇ »ó°ü¼º ¹× ÀÏÄ¡µµ, Áø´ÜÁ¤È®¼º)·Î Æò°¡ÇÏ¿´´Ù. Çѱ¹¾îÆÇ °Ë»ç µµ±¸ÀÇ ½Å·Úµµ´Â 1Æí¿¡¼ ³»Àû ÀÏÄ¡µµ°¡ ³ô¾Ò°í(Cronbach¡¯s ¥á = 0.89), °Ë»ç-Àç°Ë»çÀÇ ¹Ýº¹ÃøÁ¤ ½Ã ³ôÀº ½Å·Úµµ°¡ º¸°íµÇ¾ú´Ù(k = 0.88).
¹ø¾ÈµÈ Çѱ¹¾îÆÇ °Ë»ç µµ±¸ÀÇ Å¸´çµµ´Â Âü°íÇ¥ÁØ/ºñ±³°Ë»ç¿ÍÀÇ »ó°ü¼º ¹× ÀÏÄ¡µµ·Î Æò°¡ÇÏ¿´°í, ÃøÁ¤µµ±¸·Î¼ÀÇ Å¸´çµµ´Â Áø´ÜÁ¤È®¼ºÀ¸·Î Æò°¡ÇÏ¿´´Ù. Âü°íÇ¥ÁØ/ºñ±³°Ë»ç¿ÍÀÇ »ó°ü¼º ¹× ÀÏÄ¡µµ´Â 1Æí¿¡¼ CAARS¿ÍÀÇ »ó°ü¼ºÀÌ ÇÏÀ§ Ç׸ñ ¸ðµÎ¿¡¼ ³ô¾Ò°í(r = 0.53 ~ 0.78), Áø´ÜÁ¤È®¼ºÀº 1Æí¿¡¼ ÃÑ 18¹®Ç×ÀÇ ¹Î°¨µµ 0.71, ƯÀ̵µ 0.80, AUC 0.81, screener 6¹®Ç×ÀÇ ¹Î°¨µµ 0.63, ƯÀ̵µ 0.80, AUC 0.75·Î º¸°íµÇ¾ú´Ù.
¼ÒÀ§¿øÈ¸´Â Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµÀÇ ³»ÀûÀÏÄ¡µµ ¹× °Ë»ç-Àç°Ë»çÀÇ ¹Ýº¹ÃøÁ¤ ½Å·Úµµ, ºñ±³°Ë»çÀÎ CAARS¿ÍÀÇ »ó°ü¼º ¹× Áø´ÜÁ¤È®¼ºÀÌ ³ôÀº ¼öÁØÀ¸·Î º¸°íµÇ¾î µ¿ ôµµÀÇ ½Å·Úµµ ¹× Ÿ´çµµ¸¦ ÀÔÁõÇϱ⿡ ÃæºÐÇÏ´Ù´Â ÀǰßÀ̾ú´Ù.
°á·Ð
µû¶ó¼, ¼ÒÀ§¿øÈ¸´Â ÇöÀç ¹®ÇåÀû ±Ù°Å¸¦ ¹ÙÅÁÀ¸·Î ´ÙÀ½°ú °°ÀÌ °ËÅä°á°ú¸¦ Á¦½ÃÇÏ¿´´Ù.
Çѱ¹¾îÆÇ ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç(Measurement using Korean Adult ADHD Self Report Scale)´Â ¼ºÀÎ ADHD ÀÇ½É È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÀÚ°¡º¸°íôµµ¸¦ ÀÌ¿ëÇÏ¿© ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶Çϴµ¥ ÀÖ¾î ¾ÈÀü¼º ¹× À¯È¿¼ºÀÌ ÀÖ´Â ±â¼úÀÌ´Ù(±Ù°ÅÀÇ ¼öÁØ C).
½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸´Â ½ÅÀÇ·á±â¼úÆò°¡¿¡ °üÇÑ ±ÔÄ¢ Á¦3Á¶10Ç׿¡ ÀǰŠ¡°¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç¡±¿¡ ´ëÇØ ¼ÒÀ§¿øÈ¸ °ËÅä°á°ú¿¡ ±Ù°ÅÇÏ¿© ´ÙÀ½°ú °°ÀÌ ½ÉÀÇÇÏ¿´´Ù.
¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö ÀÚ°¡º¸°íôµµ °Ë»ç´Â ¼ºÀÎ ADHD ÀÇ½É È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÀÚ°¡º¸°íôµµ¸¦ ÀÌ¿ëÇÏ¿© ¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾ÖÀÇ Áø´ÜÀ» º¸Á¶Çϴµ¥ ÀÖ¾î ¾ÈÀü¼º ¹× À¯È¿¼ºÀÌ ÀÖ´Â ±â¼úÀÌ´Ù(±Ù°ÅÀÇ ¼öÁØ C).
½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸ÀÇ ½ÉÀǰá°ú´Â ¼ÒÀ§¿øÈ¸ÀÇ °ËÅä °á°ú¿Í ÇÔ²² 2021³â 4¿ù 8ÀÏ º¸°Çº¹ÁöºÎÀå°ü¿¡°Ô º¸°íµÇ¾úÀ¸¸ç, 2021³â 5¿ù 12ÀÏ °øÇ¥µÇ¾ú´Ù(º¸°Çº¹ÁöºÎ °í½Ã Á¦2021-139È£, 2021.05.12.).
Ű¿öµå
¼ºÀÎ ÁÖÀǷ°áÇ̰úÀ×ÇൿÀå¾Ö; ÀÚ°¡º¸°íôµµ; ¾ÈÀü¼º; À¯È¿¼º
Adult Attention-Deficit Hyperactivity Disorder; ASRS; Safety; Effectiveness
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸